NYSE · Biotechnology

NVO (NVO) Stock

$45.17 -0.35% NYSE: NVO Healthcare

Valuation

MetricValue
Price$45.17
Market Cap$200.58B
P/E Ratio11.63
P/B Ratio6.10
P/S Ratio4.11
EPS (TTM)$23.03
52-Week High$64.16
52-Week Low$35.12
Dividend Yield2.46%

Financials & Margins

MetricValue
ROE59.09%
ROA19.57%
ROCE39.93%
Gross Margin41.30%
Operating Margin41.30%
Net Margin35.35%
Debt/Equity0.63
Current Ratio0.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$140.8B$177.0B$232.3B$290.4B$309.1B
Operating Profit$58.6B$74.8B$102.6B$128.3B$127.7B
Net Profit$47.8B$55.5B$83.7B$101.0B$102.4B
EPS$10.37$12.22$18.62$22.63$23.03
Op Margin41.6%42.3%44.2%44.2%41.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$194.5B$241.3B$314.5B$465.8B$542.9B
Total Liabilities$123.8B$157.8B$207.9B$322.3B$348.9B
Cash$10.7B$12.7B$14.4B$15.7B$26.5B
Borrowings$26.6B$25.8B$27.0B$102.8B$131.0B

Latest News

3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026 Motley Fool · Jul 11, 2026 Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? Motley Fool · Jul 10, 2026 NVO Rallies 11% in a Month: How Should Investors Play the Stock? Zacks · Jul 10, 2026 AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments GlobeNewswire · Jul 10, 2026 Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$55.0B$78.9B$108.9B$121.0B$119.1B
Investing Cash Flow$-39.0B$-39.7B$-82.8B$-180.2B$-169.3B
Financing Cash Flow$-19.4B$-24.1B$-29.9B$-20.2B$-1.4B
Net Cash Flow$-1.5B$1.9B$1.7B$1.3B$10.8B
Free Cash Flow$47.6B$64.1B$70.0B$69.7B$29.0B

Valuation & Return Ratios

MetricValue
PEG Ratio2.32
EV / EBITDA8.38
FCF Yield3.61%
Quick Ratio0.66
Interest Coverage86.86
Return 1Y-14.66%
Return 3Y-47.74%
Return 5Y20.44%

Ownership

Insiders Held0.01%
Institutions Held9.91%
Institutions Float Held9.91%
Institutional HolderSharesReport Date
Dodge & Cox Inc.19,333,7502026-03-31
LOOMIS SAYLES & CO L P17,017,3152026-03-31
Franklin Resources, Inc.16,083,4792026-03-31
Capital International Investors11,795,8502026-03-31
Susquehanna International Group, LLP11,106,1112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABT $109.49 -0.79% 36.69 $189.46B 2.21%
AMGN $435.89 +1.40% 27.15 $235.25B 2.29%
AZN $161.96 -0.10% 24.78 $251.18B 1.28%
GILD $148.94 +1.78% -56.96 $184.92B 2.21%
GSKGSK plc $51.58 9.28 $103.73B 3.49%

About NVO

NVO is led by CEO Maziar Mike Doustdar, employs 77,406 people, headquartered in Bagsvaerd, DK, publicly traded since 1981.

NVO stock trades at $45.17 with a market capitalization of $200.58B. The stock is valued at a price-to-earnings (P/E) ratio of 11.63, price-to-book of 6.10, price-to-sales of 4.11. Over the past 52 weeks the stock has ranged between $35.12 and $64.16, and currently trades 29.6% below its 52-week high. It pays a dividend yielding 2.46%.

On profitability, NVO generates a return on equity (ROE) of 59.09% — well above the market average, a sign of a high-quality business, return on capital employed of 39.93%, an operating margin of 41.30%, a net profit margin of 35.35%.

In its most recent fiscal year, NVO reported annual revenue of $309.1B, net profit of $102.4B, revenue has compounded at 19.5% a year over the last five years, profit at 19.4% a year.

The balance sheet shows a debt-to-equity ratio of 0.63, a current ratio of 0.80, total assets of $542.9B, $26.5B in cash and equivalents.

NVO has a beta of 0.35 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides